IKS Inventurus Knowledge Solutions Q3 FY25 results (Oct–Dec 2024) and concall
Inventurus Knowledge Solutions (IKS) reported strong Q3 FY25 results, with revenue growing 16% YoY to ₹657.2 crores and EBITDA margin expanding to nearly 31%. The company secured significant deals, including a 15-year contract with Palomar Health and a JV with Radiology Partners, while also launching its GenAI-powered Scribble Now suite. Despite strategic customer base optimization and AQuity integration-related revenue dampening, IKS demonstrated robust growth and margin expansion, driven by accelerated cross-sell and operational efficiencies.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 240 | 241 |
| EBITDA | 116 | 103 |
| Net profit | 92 | 83 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
